2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
Autor(es) y otros:
Fecha de publicación:
2021
Versión del editor:
Citación:
Annals of the Rheumatic Diseases (2021); doi:10.1136/annrheumdis-2021-221366
Patrocinado por:
European Alliance of Associations in Rheumatology (EULAR) [CLI122]; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC); NIHR Newcastle Biomedical Research Centre in Ageing and Long-Term Conditions; Research Into Inflammatory Arthritis Centre vs Arthritis (...)
Colecciones
- Artículos [36307]